Neurizon Therapeutics Ltd
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neur… Read more
Neurizon Therapeutics Ltd (NUZ) - Total Liabilities
Latest total liabilities as of June 2025: AU$1.54 Million AUD
Based on the latest financial reports, Neurizon Therapeutics Ltd (NUZ) has total liabilities worth AU$1.54 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Neurizon Therapeutics Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how Neurizon Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Neurizon Therapeutics Ltd Competitors by Total Liabilities
The table below lists competitors of Neurizon Therapeutics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ta Yih Industrial Co Ltd
TW:1521
|
Taiwan | NT$1.11 Billion |
|
DRA Global Ltd
AU:DRA
|
Australia | AU$288.26 Million |
|
Bitcoin Well Inc.
OTCQB:BCNWF
|
USA | $43.02 Million |
|
Gold Pacific Co. Ltd
KQ:038530
|
Korea | ₩8.14 Billion |
|
Coheris SA
PA:COH
|
France | €17.04 Million |
|
GTPL Hathway Limited
NSE:GTPL
|
India | ₹25.24 Billion |
|
Mackolik Internet Hizmetleri Ticaret A.S.
IS:MACKO
|
Turkey | TL173.83 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down Neurizon Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neurizon Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neurizon Therapeutics Ltd (2001–2025)
The table below shows the annual total liabilities of Neurizon Therapeutics Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$1.54 Million | +71.55% |
| 2024-06-30 | AU$896.61K | -59.99% |
| 2023-06-30 | AU$2.24 Million | +0.33% |
| 2022-06-30 | AU$2.23 Million | 0.00% |
| 2021-06-30 | AU$2.23 Million | +7.75% |
| 2020-06-30 | AU$2.07 Million | -6.62% |
| 2019-06-30 | AU$2.22 Million | +94.77% |
| 2018-06-30 | AU$1.14 Million | -6.55% |
| 2017-06-30 | AU$1.22 Million | -4.72% |
| 2016-06-30 | AU$1.28 Million | +3.73% |
| 2015-06-30 | AU$1.23 Million | +80.64% |
| 2014-06-30 | AU$683.22K | +53.37% |
| 2013-06-30 | AU$445.48K | -25.07% |
| 2012-06-30 | AU$594.54K | -50.28% |
| 2011-06-30 | AU$1.20 Million | +294.76% |
| 2010-06-30 | AU$302.95K | -70.31% |
| 2009-06-30 | AU$1.02 Million | -40.45% |
| 2008-06-30 | AU$1.71 Million | -17.55% |
| 2007-06-30 | AU$2.08 Million | +40.13% |
| 2006-06-30 | AU$1.48 Million | 0.00% |
| 2005-06-30 | AU$1.48 Million | +5.47% |
| 2004-06-30 | AU$1.41 Million | +758.20% |
| 2003-06-30 | AU$163.86K | -88.75% |
| 2002-06-30 | AU$1.46 Million | +48.60% |
| 2001-06-30 | AU$979.80K | -- |